Effects of Dipeptidyl Peptidase-4 Inhibitor and Angiotensin-Converting Enzyme Inhibitor on Experimental Diabetic Kidney Disease
Tareq Al Tuhaifi(Vanderbilt University Medical Center), Agnes B. Fogo(Vanderbilt University Medical Center)
Cited by 5
Related Papers
Protective effects of PPAR agonist in acute nephrotic syndrome
|Nephrology Dialysis Transplantation|2011|49
Fibroblast-specific plasminogen activator inhibitor-1 depletion ameliorates renal interstitial fibrosis after unilateral ureteral obstruction
|Nephrology Dialysis Transplantation|2019|24